⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Protalix BioTherapeutics, Inc. Common Stock

$2.64
-0.09 (-3.13%)

Volume:

314.98K ($830.04K)

Market Capitalization:

$212.31M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Protalix BioTherapeutics Market Segments

Regular Trading Hours

-0.11(-3.83%)
Open$2.74
Close$2.64
Low$2.63
Low Change-0.11 (-4.01%)
High$2.75
High Change+0.01 (+0.36%)
Range$0.12
Volume314.38K
Dollar Volume$828.39K

Premarket

+0.01(+0.36%)
Open$2.74
Close$2.75
Low$2.74
Low Change0.00 (0.00%)
High$2.75
High Change+0.01 (+0.36%)
Range$0.01
Volume600
Dollar Volume$1.65K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.03(-1.10%)
Open$2.73
Close$2.70
Low$2.70
Low Change-0.03 (-1.10%)
High$2.73
High Change+0.00 (+0.00%)
Range$0.03
Volume83.7K
Dollar Volume$225.99K

Regular Trading Hours Yesterday

+0.06(+2.26%)
Open$2.66
Close$2.72
Low$2.64
Low Change-0.02 (-0.75%)
High$2.74
High Change+0.08 (+2.82%)
Range$0.10
Volume683.402K
Dollar Volume$1.86M

Premarket Yesterday

-0.02(-0.75%)
Open$2.65
Close$2.63
Low$2.63
Low Change-0.02 (-0.75%)
High$2.67
High Change+0.02 (+0.75%)
Range$0.04
Volume897
Dollar Volume$2.36K

Protalix BioTherapeutics News

There is no current news for this stock at the moment.

Protalix BioTherapeutics Top Trades

Protalix BioTherapeutics's top trade so far today returned +0.36%, while the top short trade returned -4.36%.

Protalix BioTherapeutics Moving Averages

5 Day Moving Average (SMA5)$2.67
10 Day Moving Average (SMA10)$2.63
20 Day Moving Average (SMA20)$2.49
50 Day Moving Average (SMA50)$2.42
100 Day Moving Average (SMA100)$2.25
200 Day Moving Average (SMA200)$2.26

Protalix BioTherapeutics Statistics

Average Volume (30 Days)779.9K
P/E Ratio (Current)11.13
EPS (Current)$0.24
Dividend Yield0.00%
Free Cash Flow$7.67M
Cash Ratio0.87
Current Ratio2.94
Quick Ratio1.91
Debt to Equity0.00
Enterprise Value$187.71M
EV to EBITDA7.55
EV to Sales2.33
Price to Book3.01
Price to Cash Flow21.68
Price to Free Cash Flow28.06
Price to Sales2.67
Return on Assets0.17%
Return on Equity0.27%

Protalix BioTherapeutics Stock Splits

There has been 1 stock split for Protalix BioTherapeutics (PLX). The reverse stock split occured on December 20, 2019 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Dec 20, 2019Reverse10:1

Protalix BioTherapeutics Dividends

There have been no dividends for Protalix BioTherapeutics (PLX).